Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: S$0.51 M
• Last 3 months FTD volume: S$1.41 M
• Last year FTD volume: S$1.41 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	S$2.03 M	S$2.15 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	S$11.46 M	S$37.11 M	🇺🇸 USA
Ultragenyx RARE	S$2.03 M	S$6.04 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	S$10.27 M	S$24.62 M	🇺🇸 USA
Thermo Fisher Scientific TMO	S$11.3 M	S$0.20 B	🇺🇸 USA
Esperion Therapeutics ESPR	S$5.29 M	S$19.32 M	🇺🇸 USA
Illumina ILMN	S$16.54 M	S$66.14 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	S$1.28 M	S$10.47 M	🇺🇸 USA
Aerie Pharmaceuticals AERI	N/A	S$0.94 M	🇺🇸 USA